{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:30:26Z","timestamp":1757781026509},"reference-count":54,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.vaccine.2010.06.089","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T08:28:09Z","timestamp":1278577689000},"page":"6065-6075","source":"Crossref","is-referenced-by-count":10,"title":["Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies"],"prefix":"10.1016","volume":"28","author":[{"given":"Karina","family":"Ramirez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanina","family":"Ditamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Galen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Les W.J.","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"December (6866)","key":"10.1016\/j.vaccine.2010.06.089_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/414837a","article-title":"Delivering death in the mail","volume":"414","author":"Knight","year":"2001","journal-title":"Nature"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.06.089_bib2","article-title":"Is new always better than old?: the development of human vaccines for anthrax","volume":"5","author":"Baillie","year":"2009","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.089_bib3","unstructured":"Emergent, BioSolutions., BioThrax (Anthrax Vaccine, Adsorbed), Product Prescribing, Information, 2010. p. 1\u201316. http:\/\/www.emergentbiosolutions.com\/pdf\/emergent_biothrax_us.pdf."},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.06.089_bib4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.mam.2009.08.006","article-title":"Anthrax vaccination strategies","volume":"30","author":"Cybulski","year":"2009","journal-title":"Mol Aspects Med"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.06.089_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/hv.5.3.7308","article-title":"The anthrax vaccine: no new tricks for an old dog","volume":"5","author":"Bienek","year":"2009","journal-title":"Hum Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.06.089_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2105\/AJPH.92.5.715","article-title":"The anthrax vaccine program: an analysis of the CDC's recommendations for vaccine use","volume":"92","author":"Nass","year":"2002","journal-title":"Am J Public Health"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.06.089_bib7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/pds.1302","article-title":"Factors influencing laboratory workers\u2019 decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program","volume":"15","author":"Fowler","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2010.06.089_bib8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/aje\/kwn159","article-title":"Birth defects among infants born to women who received anthrax vaccine in pregnancy","volume":"168","author":"Ryan","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.06.089_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nm0204-112b","article-title":"US soldiers refuse to fall in line with anthrax vaccination scheme","volume":"10","author":"Ready","year":"2004","journal-title":"Nat Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.06.089_bib10","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JCM.43.4.1992-1994.2005","article-title":"Characterization of a Bacillus anthracis isolate causing a rare case of fatal anthrax in a 2-year-old boy from Hong Kong","volume":"43","author":"Cheung","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2010.06.089_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/jama.287.7.869","article-title":"Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant","volume":"287","author":"Freedman","year":"2002","journal-title":"JAMA"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2010.06.089_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MMBR.68.4.617-629.2004","article-title":"Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines","volume":"68","author":"Phipps","year":"2004","journal-title":"Microbiol Mol Biol Rev"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.089_bib13","first-page":"129","article-title":"Vaccines: countering anthrax: vaccines and immunoglobulins","volume":"46","author":"Grabenstein","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.06.089_bib14","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1128\/IAI.72.8.4637-4646.2004","article-title":"Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers","volume":"72","author":"Capozzo","year":"2004","journal-title":"Infect Immun"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.06.089_bib15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4049\/jimmunol.182.2.1211","article-title":"Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost","volume":"182","author":"Ramirez","year":"2009","journal-title":"J Immunol"},{"issue":"October Suppl. (2)","key":"10.1016\/j.vaccine.2010.06.089_bib16","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.06.089_bib17","first-page":"81","article-title":"Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial","volume":"8","author":"Black","year":"1990","journal-title":"Chilean Typhoid Committee. Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2010.06.089_bib18","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1128\/IAI.59.11.4291-4293.1991","article-title":"Immunogenicity of Salmonella typhi Ty21a vaccine for young children","volume":"59","author":"Murphy","year":"1991","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.06.089_bib19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1128\/IAI.61.3.1149-1151.1993","article-title":"Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children","volume":"61","author":"Cryz","year":"1993","journal-title":"Infect Immun"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2010.06.089_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/infdis\/166.2.451","article-title":"Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4\u20136-year-old Thai children","volume":"166","author":"Olanratmanee","year":"1992","journal-title":"J Infect Dis"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2010.06.089_bib21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1086\/596066","article-title":"Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine","volume":"199","author":"Galen","year":"2009","journal-title":"J Infect Dis"},{"issue":"July Suppl. (1)","key":"10.1016\/j.vaccine.2010.06.089_bib22","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jcpa.2007.04.004","article-title":"The challenges of vaccine responses in early life: selected examples","volume":"137","author":"Siegrist","year":"2007","journal-title":"J Comp Pathol"},{"issue":"November (48)","key":"10.1016\/j.vaccine.2010.06.089_bib23","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1016\/j.vaccine.2008.09.010","article-title":"Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy","volume":"26","author":"Baillie","year":"2008","journal-title":"Vaccine"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2010.06.089_bib24","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.4049\/jimmunol.176.9.5671","article-title":"Neonatal immunization with a Sindbis virus\u2013DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies","volume":"176","author":"Capozzo","year":"2006","journal-title":"J Immunol"},{"issue":"April (1\u20132)","key":"10.1016\/j.vaccine.2010.06.089_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2008.01.007","article-title":"Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization","volume":"333","author":"Li","year":"2008","journal-title":"J Immunol Methods"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2010.06.089_bib26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1086\/423937","article-title":"Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax","volume":"190","author":"Quinn","year":"2004","journal-title":"J Infect Dis"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.06.089_bib27","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1128\/IAI.73.11.7495-7501.2005","article-title":"Murine macrophages kill the vegetative form of Bacillus anthracis","volume":"73","author":"Kang","year":"2005","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.06.089_bib28","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/IAI.01242-06","article-title":"Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis","volume":"75","author":"Stokes","year":"2007","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.06.089_bib29","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/IAI.73.6.3408-3414.2005","article-title":"Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines","volume":"73","author":"Aulinger","year":"2005","journal-title":"Infect Immun"},{"issue":"September (27\u201328)","key":"10.1016\/j.vaccine.2010.06.089_bib30","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1016\/j.vaccine.2004.03.025","article-title":"Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy","volume":"22","author":"Vindurampulle","year":"2004","journal-title":"Vaccine"},{"issue":"July (24)","key":"10.1016\/j.vaccine.2010.06.089_bib31","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/S0264-410X(03)00336-0","article-title":"Transfer of antibody via mother's milk","volume":"21","author":"Van de","year":"2003","journal-title":"Vaccine"},{"issue":"October (12\u201313)","key":"10.1016\/j.vaccine.2010.06.089_bib32","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.micinf.2007.08.002","article-title":"Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax","volume":"9","author":"Klinman","year":"2007","journal-title":"Microbes Infect"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2010.06.089_bib33","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.06.089_bib34","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.06.089_bib35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11095-005-9078-7","article-title":"Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome\u2013protamine\u2013DNA particles","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm Res"},{"issue":"June (Pt 6)","key":"10.1016\/j.vaccine.2010.06.089_bib36","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"issue":"November (4)","key":"10.1016\/j.vaccine.2010.06.089_bib37","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2958.2001.02695.x","article-title":"Fate of germinated Bacillus anthracis spores in primary murine macrophages","volume":"42","author":"Guidi-Rontani","year":"2001","journal-title":"Mol Microbiol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.06.089_bib38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-51-10-821","article-title":"In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody","volume":"51","author":"Welkos","year":"2002","journal-title":"J Med Microbiol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2010.06.089_bib39","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.4049\/jimmunol.178.5.2646","article-title":"Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis","volume":"178","author":"Glomski","year":"2007","journal-title":"J Immunol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2010.06.089_bib40","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.4049\/jimmunol.0901581","article-title":"Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encopassing infection-specific epitopes","volume":"184","author":"Ingram","year":"2010","journal-title":"J. Immunol."},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.06.089_bib41","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/IAI.00070-07","article-title":"Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge","volume":"75","author":"Bielinska","year":"2007","journal-title":"Infect Immun"},{"issue":"May (18)","key":"10.1016\/j.vaccine.2010.06.089_bib42","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1016\/j.vaccine.2007.01.075","article-title":"Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine","volume":"25","author":"Zeng","year":"2007","journal-title":"Vaccine"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2010.06.089_bib43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.all.0000162309.97480.45","article-title":"Cytokines, allergy, and asthma","volume":"5","author":"Ngoc","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2010.06.089_bib44","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.4049\/jimmunol.181.8.5785","article-title":"Effect of CpG oligonucleotides on vaccine-induced B cell memory","volume":"181","author":"Tross","year":"2008","journal-title":"J Immunol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.06.089_bib45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette\u2013Guerin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2010.06.089_bib46","doi-asserted-by":"crossref","first-page":"e1044","DOI":"10.1371\/journal.pone.0001044","article-title":"Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response","volume":"2","author":"Kolla","year":"2007","journal-title":"PLoS One"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.06.089_bib47","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/CVI.00015-08","article-title":"Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background","volume":"15","author":"Abboud","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.06.089_bib48","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/IAI.00828-08","article-title":"Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge","volume":"77","author":"Osorio","year":"2009","journal-title":"Infect Immun"},{"issue":"July (24)","key":"10.1016\/j.vaccine.2010.06.089_bib49","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1016\/S0264-410X(03)00342-6","article-title":"Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants","volume":"21","author":"Siegrist","year":"2003","journal-title":"Vaccine"},{"issue":"August (14\u201315)","key":"10.1016\/j.vaccine.2010.06.089_bib50","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0264-410X(98)00100-5","article-title":"Determinants of infant responses to vaccines in presence of maternal antibodies","volume":"16","author":"Siegrist","year":"1998","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.06.089_bib51","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/JOM.0b013e318157d305","article-title":"Assessing the safety of anthrax immunization in US Army aircrew members via physical examination","volume":"49","author":"Downing","year":"2007","journal-title":"J Occup Environ Med"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.06.089_bib52","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L","article-title":"Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice","volume":"28","author":"Siegrist","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2010.06.089_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00412-09","article-title":"Construction of recombinant attenuated Salmonella enterica Typhimurium vaccine (RASV) vector strains for safety in newborn and infant mice","author":"Gunn","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.06.089_bib54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/IAI.00916-09","article-title":"A new generation of stable, non-antibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors","volume":"78","author":"Galen","year":"2010","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10009308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10009308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T18:57:40Z","timestamp":1591469860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10009308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":54,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0264410X10009308"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.06.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}